Attached files
| file | filename |
|---|---|
| EX-32 - EX-32 - ASPEN AEROGELS INC | aspn-ex32_6.htm |
| EX-31.2 - EX-31.2 - ASPEN AEROGELS INC | aspn-ex312_8.htm |
| EX-31.1 - EX-31.1 - ASPEN AEROGELS INC | aspn-ex311_7.htm |
| EX-21.1 - EX-21.1 - ASPEN AEROGELS INC | aspn-ex211_796.htm |
| EX-10.23 - EX-10.23 - ASPEN AEROGELS INC | aspn-ex1023_799.htm |
| EX-10.15.4 - EX-10.15.4 - ASPEN AEROGELS INC | aspn-ex10154_797.htm |
| EX-10.15.3 - EX-10.15.3 - ASPEN AEROGELS INC | aspn-ex10153_798.htm |
| 10-K - 10-K - ASPEN AEROGELS INC | aspn-10k_20161231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Aspen Aerogels, Inc.:
We consent to the incorporation by reference in the registration statements (Nos. 333-198124 and 333-209995) on Form S-8 of Aspen Aerogels, Inc. of our reports dated March 2, 2017, with respect to the consolidated balance sheets of Aspen Aerogels, Inc. as of December 31, 2016 and 2015, and the related consolidated statements of operations, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2016, and the related financial statement schedule, which reports appear in the December 31, 2016 annual report on Form 10-K of Aspen Aerogels, Inc.
/s/ KPMG LLP
Boston, Massachusetts
March 2, 2017